The Capital Markets Day 2022 was held on Tuesday, August 30, 2022, at 14:30-17:30 at Helio GT30, Grev Turegatan 30, in Stockholm.
Access the video recording of the event
Agenda
The event starts at 14:30 with coffee and networking, before the program starts at 15:00.
Time |
Program |
|
15:00 |
Welcome |
|
15:05 |
Cereno’s Commitment to Transforming Cardiovascular Disease Management |
|
15:20 |
Overview of Cardiovascular Disease and Cereno’s Focus Areas |
|
15:30 |
Understanding PAH: Debilitating Rare Disease |
|
15:45 |
Clinical Phase II Study Design with CS1 |
|
15:50 |
CardioMEMS – Phase II Clinical Collaboration Between Abbott and Cereno |
|
16:05 |
Cereno’s Drug Candidate CS1 to Treat PAH and Broader Potential |
|
16:20 |
Cereno’s Preclinical Candidates Potential to Break New Ground |
|
16:25 |
CS585 – A First-In-Class Compound Targeting the IP Receptor for Prevention of Thrombosis Without Increased Risk of Bleeding |
|
16:40 |
CS014 – A Novel HDAC Inhibitor Regulating Platelet Activity, Fbrinolysis and Clot Stability for Prevention of Thrombosis Without Increased Risk of Bleeding |
|
16:55 |
Panel: The Need for True Innovation in CVD Management – Focus on PAH and Thrombosis Moderated by moderator Dr. Björn Dahlöf |
|
17:10 |
Questions from Audience |
|
17:20 |
Concluding Words |